A NEW ORAL RENAL VASODILATOR, FENOLDOPAM

被引：91

作者：

STOTE, RM ^{[1
]}

DUBB, JW ^{[1
]}

FAMILIAR, RG ^{[1
]}

ERB, BB ^{[1
]}

ALEXANDER, F ^{[1
]}

机构：

[1] SK&F LABS,PHILADELPHIA,PA 19101

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 03期

关键词：

D O I：

10.1038/clpt.1983.173

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：309 / 315

页数：7

共 15 条

[1] RENAL VASODILATORS AND HYPERTENSION [J].

ACKERMAN, DM ;

WEINSTOCK, J ;

WIEBELHAUS, VD ;

BERKOWITZ, B .

DRUG DEVELOPMENT RESEARCH, 1982, 2 (03) :283-297

[2] ALDOSTERONE AND DOPAMINE-RECEPTORS IN THE KIDNEY - SITES FOR PHARMACOLOGIC MANIPULATION OF RENAL-FUNCTION [J].

ADAM, WR .

KIDNEY INTERNATIONAL, 1980, 18 (05) :623-635

[3] EFFECTS OF INCREASED SODIUM DELIVERY ON DISTAL TUBULAR SODIUM REABSORPTION WITH AND WITHOUT VOLUME EXPANSION IN MAN [J].

BUCKALEW, VM ;

WALKER, BR ;

PUSCHETT, JB ;

GOLDBERG, M .

JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2336-&

[4] PHOSPHATURIC EFFECT OF DOPAMINE IN DOGS - POSSIBLE ROLE OF INTRARENALLY PRODUCED DOPAMINE IN PHOSPHATE REGULATION [J].

CUCHE, JL ;

MARCHAND, GR ;

GREGER, RF ;

LANG, FC ;

KNOX, FG .

JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (01) :71-76

[5] CARDIOVASCULAR DOPAMINE RECEPTOR STIMULATION ANTAGONIZED BY METOCLOPRAMIDE [J].

DAY, MD ;

BLOWER, PR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (04) :276-278

[6] OBSERVATIONS ON MECHANISM OF DECREASED TUBULAR REABSORPTION OF SODIUM + WATER DURING SALINE LOADING [J].

EARLY, LE ;

FRIEDLER, RM .

JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (10) :1928-&

[7]

HAHN RA, 1982, J PHARMACOL EXP THER, V223, P305

[8] ANTAGONISM OF THE RENAL VASODILATOR ACTIVITY OF DOPAMINE BY METOCLOPRAMIDE [J].

HAHN, RA ;

WARDELL, JR .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 314 (02) :177-182

[9]

KIM JK, 1980, PHARMACOL REV, V31, P169

[10]

KNOX FG, 1973, MAYO CLIN PROC, V48, P565

← 1 2 →